MedPath

REGION STOCKHOLM

REGION STOCKHOLM logo
🇸🇪Sweden
Ownership
Private
Employees
5K
Market Cap
-
Website
https://www.sll.se/jobb

Clinical Trials

102

Active:17
Completed:19

Trial Phases

5 Phases

Early Phase 1:1
Phase 1:2
Phase 2:3
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (57 trials with phase data)• Click on a phase to view related trials

Not Applicable
49 (86.0%)
Phase 2
3 (5.3%)
Phase 1
2 (3.5%)
Phase 3
2 (3.5%)
Early Phase 1
1 (1.8%)

RECURrence of Atrial Fibrillation After Cardioversion of Patients Randomized to Dapagliflozin or Usual Care

Not Applicable
Recruiting
Conditions
Atrial Fibrillation (AF)
Interventions
Drug: Dapagliflozin 10 mg once daily
First Posted Date
2025-09-23
Last Posted Date
2025-09-23
Lead Sponsor
Region Stockholm
Target Recruit Count
1600
Registration Number
NCT07187570
Locations
🇸🇪

Linköping university hosptial, Linköping, Sweden

🇸🇪

Örebro University hospital, Örebro, Sweden

🇸🇪

Södersjukhuset, Stockholm, Sweden

and more 4 locations

Biomarkers in the Endometrial Fluid, Tissue, and Follicular Fluid of Moderate/Severe Endometriosis Patients

Not yet recruiting
Conditions
Endometriosis
First Posted Date
2025-09-19
Last Posted Date
2025-09-19
Lead Sponsor
Region Stockholm
Target Recruit Count
90
Registration Number
NCT07182643
Locations
🇸🇪

Karolinska Institute and Karolinska University Hospital Huddinge, Stockholm, Sweden

Registry BAsed Optimization Of Therapy in Heart Failure

Not Applicable
Recruiting
Conditions
Heart Failure
First Posted Date
2025-09-04
Last Posted Date
2025-09-04
Lead Sponsor
Region Stockholm
Target Recruit Count
1000
Registration Number
NCT07154758
Locations
🇸🇪

Sahlgrenska Universitetssjukhuset, Gothenburg, Sweden

🇸🇪

Hemse vårdcentral, Hemse, Sweden

🇸🇪

Länssjukhuset Ryhov, Jönköping, Sweden

and more 3 locations

Immune System Effects in Children Born to Women With Multiple Sclerosis Treated With Monoclonal Antibody Therapy During Pregnancy

Not yet recruiting
Conditions
Multiple Sclerosis
Pregnancy
Interventions
Drug: monoclonal CD-20 antibodies
Drug: Other treatment
First Posted Date
2025-09-02
Last Posted Date
2025-09-02
Lead Sponsor
Region Stockholm
Target Recruit Count
111
Registration Number
NCT07149662
Locations
🇸🇪

Academic specialist center, Center for Neurology, Stockholm, Sweden

Exposure-Based CBT for Youth With Blood and Injection Phobia and Chronic Illness

Not Applicable
Not yet recruiting
Conditions
Blood Injury Phobia
Injection Fear
First Posted Date
2025-08-15
Last Posted Date
2025-08-15
Lead Sponsor
Region Stockholm
Target Recruit Count
30
Registration Number
NCT07125287
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 20
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.